Dana is the CTO at the Israel Innovation Authority – the largest government funding entity in Israel investing over 0.5B$ a year in the High-Tech ecosystem.
In her current role Dana leads data driven decision making mechanisms. In addition, she also takes a leading part in the implementation of the Bio-convergence national plan.
Dana has a PhD in multidisciplinary cancer research from Dundee University (Marie Curie fellowship) and a Postdoc in stem cell research from Tel Aviv University.
Previously to her current role Dana worked in the drug development industry with her last role being VP strategic planning and alliances.
Dana was also the representative of the Israel Innovation Authority to the National COVID19 Task Force.